Overview

The DIA Medical Writing & Scientific Communication Conference 2026 plans to bring together global and regional experts to explore how medical writing and scientific communication are evolving amid regulatory harmonization, digital transformation, rising ethical expectations, and India’s expanding role in global healthcare development.

Based on participant feedback from the 2025 edition, the 2026 conference has been deliberately designed as a focused, two-day, in-person, single-track program to enable deeper discussions, shared learning, and maximum engagement across all sessions. The program spans regulatory writing, scientific publications, patient-centric communication, AI and automation, quality and compliance, clinical and real-world evidence communication, and industry-partner collaboration, supported by practical insights and real-world perspectives.

Featured

Want to learn more about DIA Medical Writing & Scientific Communication Conference - 2026 ? You've come to the right site!

Exhibits

Learn more

Exhibits

Learn more

Who should attend?

Who should Attend?

Medical Writers & Scientific Communicators
Regulatory Affairs & Clinical Development Leaders
Publication Professionals & Medical Affairs Teams
GCC Leaders & Capability Heads
CROs, Service Providers & Technology Partners
Quality, Compliance & Audit Professionals

Learning objectives

By attending this conference, participants will gain insight into:

• Evolving global regulatory and publication requirements and their impact on medical writing practices.

• Ethical, transparent, and patient-centric approaches to regulatory and scientific communication.

• Practical applications of AI, digitization, and automation, including governance and quality considerations.

• Quality, compliance, and risk management across the medical writing lifecycle.

• Effective communication of clinical and real-world evidence for diverse stakeholder needs.

• Emerging GCC models, talent development strategies, and business insights shaping the future of medical writing.

• Trust-based collaboration frameworks with CROs and service providers that drive long-term value

This focused format ensures participants gain actionable insights, meaningful peer interaction, and a clear view of future frontiers in medical writing and scientific communication.

Program Committee

Pooja Phogat, PHD Founder and Co-CEO
Krystelis Ltd., India
Hetal Shah, Ph.D Founder - Director
MeWriT Healthcare Consulting, India
Annie Jose Associate Director, Medical Writing
GSK, Bengaluru, India
Sherin Babykutty Associate Director – Scientific Writing, Global Scientific Communications
Eli Lilly and Company, India
Sam Thomarayil Mathew, Ph.D Director, Medical Delivery
AstraZeneca India Pvt Ltd, India
Pinki Rajeev, Ph.D Sr. Director Medical Communications
Parexel International, India
Priyanka Tiwari Associate Director, Global Medical Writing
Thermofisher Scientific, India
Sonia Philipose, Ph.D Medical Communications and Content Solutions Lead- Vaccines
Pfizer Inc, India
Ashok Kumar Swain, MD General Manager & Executive Director
DIA, India